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Abstract A survey was performed in May 2013 to assess
methicillin-resistant Staphylococcus aureus (MRSA) nasal
colonization in healthy children attending 26 municipal
daycare centres in Palermo, Italy. Of the 500 children, ten
(2 %) tested positive. Eight MRSA isolates were tst1-
positive ST22-MRSA-IVa, spa t223; the other two isolates
were identified as ST1-IVa and ST398-V, respectively.
tst1-positive ST22-MRSA, spa t223 has been previously
identified only in the Middle Eastern area.
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Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is a
major pathogen in healthcare and community settings [1].
One of the most challenging issues in the evolution of
MRSA epidemiology is the emergence and spread of
community-associated MRSA (CA-MRSA). CA-MRSA
strains are generally susceptible to a wider spectrum of
non-b-lactam antibiotics and have smaller staphylococcal
cassette chromosome mec (SCCmec) elements (types IV or
V) than do healthcare-associated MRSA (HA-MRSA)
strains, but they often carry the genes for Panton–Valentine
leukocidin. However, blurring of boundaries between the
healthcare and the community setting is increasingly
jeopardizing the differentiation of HA- from CA-MRSA
infections.
Only a small number of studies have been conducted to
assess MRSA nasal colonization in healthy children in the
community [1–4]. Here we report the results of a survey
performed to detect MRSA nasal colonization in healthy
preschool children in Palermo, southern Italy, an area with
high levels of endemic MRSA infections [5].
Methods
In May 2013 we conducted a point-prevalence study in 26
municipal daycare centres located in Palermo, Italy, hosting
children aged \3 years. All of the 988 preschool children
who attended the centres were considered eligible to be
enrolled in the investigation. Informed consent was
obtained from the childrens’ parents or guardians. A ques-
tionnaire was also used to investigate possible risk factors
for MRSA carriage, such as household size, number and age
of siblings, contact with animals, medical history, symp-
toms of upper respiratory tract infection at the time of
sampling, recent use of antibiotics and prior hospitalization.
Specimens for culture were obtained from both anterior
nares with a sterile cotton swab. Each swab was transferred
to the microbiology laboratory within 2 h from sampling,
immediately placed in brain–heart infusion broth (OXOID,
Basingstoke, UK) and incubated at 35 C overnight.
Mannitol salt agar plates were then inoculated and, after a
further incubation at 35 C for 48 h, presumptive S. aureus
isolates were identified according to standard methods.
MRSA isolates were screened for by plating colonies onto
oxacillin agar (Mueller–Hinton with oxacillin 6 mg/L).
Isolates were confirmed as MRSA by the cefoxitin disk
diffusion test and PCR assay for the detection of mecA.
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Staphylococcal cassette chromosome mec (SCCmec)
typing was performed by the multiplex PCR method
described by Milheiric¸o et al. [6]. Multilocus sequence
typing (MLST) was performed by PCR and by the
sequencing of seven housekeeping genes, and the MLST
allelic profiles and sequence types were assigned by sub-
mission to the S. aureus MLST database (www.mlst.net).
spa typing was also carried out on the MRSA-ST22-IVa
isolates using Ridom StaphType software (www.ridom.de/
staphtype/). MRSA clones were defined by both their
multilocus sequence type (ST) and their SCCmec type.
Susceptibility to ciprofloxacin, clarithromycin, clinda-
mycin, erythromycin, gentamicin, levofloxacin, linezolid,
rifampicin, tetracycline and trimethoprim–sulfamethoxa-
zole was determined using the disk diffusion method.
Vancomycin and teicoplanin minimum inhibitory con-
centrations (MICs) were assessed by the E test. Macrolide–
lincosamide–streptogramin B (MLSB)-inducible pheno-
types were detected by the D-zone test as per European
Committee on Antimicrobial Susceptibility Testing (EU-
CAST) guidelines (www.eucast.org/clinical_breakpoints/).
Susceptibility testing results were interpreted based on
EUCAST clinical breakpoints.
The presence of lukS/lukF-PV and tst1 genes
encoding the PVL and the toxic shock syndrome toxin
1 (TSST-1), respectively, was tested for by PCR [7].
Similarly, ST22-MRSA-IVa isolates were also tested
for by PCR for the carriage of enterotoxins C and L
(sec, sel) using previously described primers and con-
ditions [7].
Results
Informed consent was obtained from the parents or
guardians of 617 children, and nasal swabs were collected
from 500 of these. Of these 500 children, 74 (14.8 %) were
S. aureus carriers. MRSA was detected in ten children
(13.5 % of S. aureus carriers and 2.0 % of all children)
who were attending nine different daycare centres.
Eight MRSA isolates were ST22-MRSA-IVa, spa t223.
Antimicrobial susceptibility testing using disk diffusion
revealed that five of these eight isolates were susceptible to
all non-b-lactam antibiotics tested and that three isolates
were resistant to tetracycline (Table 1). The tst1 gene was
detected in all eight isolates, but the enterotoxin genes sec
and sel as well as PVL-encoding genes were not found in
any isolate. Of interest, five MSSA isolates from MRSA-
negative children were also ST22, spa t223.
Two additional MRSA isolates were identified as ST1-
IVa and ST398-V, respectively, and proved to be resistant
to macrolides and tetracycline. The ST1-IVa isolate
showed a MLSB-inducible phenotype (Table 1). Both iso-
lates tested negative for lukS/lukF-PV and tst1 genes.
The isolates 3I and 23U, ST22-IVa and isolate 7L,
ST398-V showed vancomycin MIC values of 2 mg/L,
which are at the upper limit of the wild-type MIC
distribution.
No association between carriage of the MRSA and
specific risk factors arose from the answers of the child-
rens’ parents to the questionnaire. All parents of the
MRSA-positive children were of Italian nationality.
Table 1 Pattern of susceptibility to non-b-lactam antibiotics of ten methicillin-resistant Staphylococcus aureus isolates from healthy preschool
children in Palermo, Italy, 2013
MRSA isolate ST-SCCmec non-b-Lactam antibioticsa
CIP CLR DA ERY CN LEV LZD RIF SXT TE VA (MIC) TEC (MIC)
3A ST1-IVa S R Sb R S S S S S R S (1.5) S (0.75)
11B ST22-IVa S S S S S S S S S S S (1) S (1)
3I ST22-IVa S S S S S S S S S S S (2) S (0.5)
2L ST22-IVa S S S S S S S S S R S (1) S (0.38)
7L ST398-V S R R R S S S S S R S (2) S (0.75)
7M ST22-IVa S S S S S S S S S S S (1.5) S (0.75)
7S ST22-IVa S S S S S S S S S S S (1.5) S (0.5)
23U ST22-IVa S S S S S S S S S S S (2) S (0.5)
16V ST22-IVa S S S S S S S S S R S (1.5) S (0.5)
17X ST22-IVa S S S S S S S S S R S (1.5) S (0.38)
MRSA, Methicillin-resistant Staphylococcus aureus; S, susceptible; R, resistant; MIC, minimum inhibitory concentration
a CIP, Ciprofloxacin (5 lg); CLR, clarithromycin (15 lg); DA, clindamycin (2 lg); ERY, erythromycin (5 lg); CN, gentamicin (10 lg); LEV,
levofloxacin (5 lg); LZD, linezolid (30 lg); RIF, rifampicin (5 lg); SXT, sulfamethoxazole–trimethoprim (25 lg); TE, tetracycline (30 lg);
VA, vancomycin; TEC, teicoplanin
b Macrolide–lincosamide–streptogramin B (MLSB)-inducible phenotype
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According to the information provided by the question-
naires, none of the children had been hospitalized or had
taken antibiotics in the 3 months prior to their nasal sam-
pling. Moreover, none of the family members of the child
carrying the ST398-MRSA-V isolate reported any direct or
indirect exposure to livestock.
Discussion
Little data are available on the prevalence and strains of
MRSA carriage in healthy children in the community [1–
4]. To the best of our knowledge, no data are available
from Italy, a European country which is categorized as
being highly endemic for MRSA infection [5]. Our survey
detected a 2.0 % prevalence of MRSA carriage in healthy
children attending 26 municipal daycare centres in
Palermo. A similar prevalence (2.3 %; 95 % confidence
interval 1.8–2.7) was reported by a recent meta-analysis of
children recruited in kindergartens and schools or during
well-child visits in various countries around the world [1].
However, in our setting an unexpected finding was the
predominance of the tst1-positive ST22-MRSA, spa t223
strain. This strain, previously identified as a Middle Eastern
variant of UK-EMRSA-15, appears to be identical to the
‘‘Gaza strain’’ described by Biber et al. [8] as the pre-
dominant MRSA clone in healthy children and their par-
ents living in the Gaza strip [8, 9]. MRSA strains with
similar characteristics have also been reported from Saudi
Arabia, Abu Dhabi and Egypt [10]. A spa t223 strain has
also been recently described as the second most common
MRSA strain among 227 healthy volunteers from a Jor-
danian community [11]. The possible relationships
between this MRSA strain and the ST22-IVa isolates which
have been identified in several healthcare settings in our
geographic area deserves further investigation [12]. The
most likely origin of the ‘‘Gaza strain’’, according to the
hypothesis of Biber et al. [9], should be a locally prevalent
ST22-MSSA spa t223 strain. However, our findings sug-
gest that this strain has spread into a wider area, including
the Mediterranean region. The detection in our setting of
ST22-MSSA, spa t223 appears to be consistent with the
hypothesis of a local evolution towards resistance to
methicillin, which has been suggested as an alternative to
the import of EMRSA-15 into the Middle Eastern area [9].
Further intensive molecular investigations on these strains
are needed to reliably track their evolution and dissemi-
nation routes.
An alarming finding is our detection of MRSA isolates
with vancomycin MIC values of 2 mg/L in healthy com-
munity subjects. Indeed, despite these strains being cate-
gorized by EUCAST guidelines as susceptible, several
clinical studies report high rates of unfavourable clinical
response in patients infected with MRSA isolates having
MICs on the borderline of the wild-type MIC distribution
[13].
Our study has several limitations. First, it is a cross-
sectional study with a relatively small sample size. More-
over, because access to municipal child daycare centres is
primarily directed towards lower income families, our
results may not be generalizable to the city population as a
whole. Secondly, our MRSA screening method using
mannitol salt agar may have been less specific and sensitive
than isolation on chromogenic agar media, even though we
used a broth enrichment step to enhance MRSA detection
[14].
In conclusion, the molecular epidemiological charac-
teristics of MRSA isolates from healthy children in
Palermo, Italy, appear to be similar to those reported in
some Middle Eastern countries. Further studies focusing on
the molecular characterization of carriage and clinical
isolates of CA- and HA-MRSA are needed to provide more
informative data on the burden and evolution of MRSA in
our geographic area.
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